EFAMOL PURE LIQUID EVENING PRIMROSE OIL 84 MG — DIN 02231013
GAMMA-LINOLENIC ACID (EVENING PRIMROSE OIL) : 84 MG CIS-LINOLEIC ACID (EVENING PRIMROSE OIL) : 670 MG · EFAMOL RESEARCH INC. · LIQUID · wholesale supply in Canada
Health Canada status: CANCELLED POST MARKET
What is EFAMOL PURE LIQUID EVENING PRIMROSE OIL?
EFAMOL PURE LIQUID EVENING PRIMROSE OIL 84 MG contains GAMMA-LINOLENIC ACID (EVENING PRIMROSE OIL) : 84 MG CIS-LINOLEIC ACID (EVENING PRIMROSE OIL) : 670 MG. It is listed in the Health Canada Drug Product Database under DIN 02231013, held by EFAMOL RESEARCH INC., supplied as LIQUID for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 25-Oct-1999. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
Is there a generic Other Combinations Of Nutrients in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
11 holders have a Canadian DIN containing Other Combinations Of Nutrients, across 15 DINs, of which 0 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| SWISS HERBAL REMEDIES LTD. | 3 | 0 | BORACELLE CAPSULES 500MG, BORACELLE OIL OF BORAGE SEED 23.5% GAMMA LIN, BORAGE OIL 500MG - CAP | No marketed DIN |
| GENERAL NUTRITION CANADA INC. | 2 | 0 | WOMEN'S EVEN.PRIMROSE OIL1300MG SOFTGEL CAPS, WOMEN'S EVENING PRIMROSE OIL 500MG - CAP | No marketed DIN |
| TECNODIS DISTRIBUTIONS INC. | 2 | 0 | BORAGE OIL, EVENING PRIMROSE OIL | No marketed DIN |
| EFAMOL RESEARCH INC. | 1 | 0 | EFAMOL PURE LIQUID EVENING PRIMROSE OIL | No marketed DIN |
| PURITY PLUS ADVANCED NATURALS | 1 | 0 | PRIMROSA EVENING PRIMROSE OIL CONCENTRATE (1200MG) | No marketed DIN |
| RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | 1 | 0 | RATIO-HERACLINE | No marketed DIN |
| SEROYAL INTERNATIONAL INC. | 1 | 0 | AMD TAB | No marketed DIN |
| THERAPEUTIC FOODS CO. | 1 | 0 | PMG PROTOMORPHOGEN BEEF PROSTATE 164MGMS | No marketed DIN |
| THORNE RESEARCH INC. | 1 | 0 | Q-10 PLUS | No marketed DIN |
| WAH SHUN COMPANY | 1 | 0 | EVENING PRIMROSE OIL CAPSULES | No marketed DIN |
| WING QUON ENTERPRISES LTD. | 1 | 0 | YUE JIAN CAO YOU | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 84 MG |
|---|---|
| Dosage form | LIQUID |
| Route | ORAL |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Other Combinations Of Nutrients |
|---|---|
| ATC code | V06DX |
| AHFS class | 88:30.00* ; See footnote |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02231013 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2231013 |
| Brand name | EFAMOL PURE LIQUID EVENING PRIMROSE OIL |
| Generic / active ingredient | GAMMA-LINOLENIC ACID (EVENING PRIMROSE OIL) : 84 MG CIS-LINOLEIC ACID (EVENING PRIMROSE OIL) : 670 MG |
| Market authorization holder | EFAMOL RESEARCH INC. |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| ATC code | V06DX |
| ATC anatomical main group | V — Various |
| ATC therapeutic subgroup | V06DX |
| Current status | CANCELLED POST MARKET |
| Status date | 25-Oct-1999 |
| Original market date | 1997-12-17 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
0 of 15 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| AMD TAB | 50 MG | TABLET | SEROYAL INTERNATIONAL INC. | CANCELLED POST MARKET | 00705780 |
| BORACELLE CAPSULES 500MG | 16.8 % | CAPSULE | SWISS HERBAL REMEDIES LTD. | CANCELLED POST MARKET | 00702633 |
| BORACELLE OIL OF BORAGE SEED 23.5% GAMMA LIN | 87.216 MG | CAPSULE | SWISS HERBAL REMEDIES LTD. | CANCELLED POST MARKET | 02122723 |
| BORAGE OIL | 187.5 MG | CAPSULE | TECNODIS DISTRIBUTIONS INC. | CANCELLED (UNRETURNED ANNUAL) | 02241145 |
| BORAGE OIL 500MG - CAP | 115 MG | CAPSULE | SWISS HERBAL REMEDIES LTD. | CANCELLED POST MARKET | 02182335 |
| EVENING PRIMROSE OIL | 370 MG | CAPSULE | TECNODIS DISTRIBUTIONS INC. | CANCELLED (UNRETURNED ANNUAL) | 02241144 |
| EVENING PRIMROSE OIL CAPSULES | 240 MG | CAPSULE | WAH SHUN COMPANY | CANCELLED (UNRETURNED ANNUAL) | 02237447 |
| PMG PROTOMORPHOGEN BEEF PROSTATE 164MGMS | 164 MG | TABLET | THERAPEUTIC FOODS CO. | CANCELLED POST MARKET | 00190934 |
| PRIMROSA EVENING PRIMROSE OIL CONCENTRATE (1200MG) | 240 MG | CAPSULE | PURITY PLUS ADVANCED NATURALS | CANCELLED POST MARKET | 02229568 |
| Q-10 PLUS | 30 MG | CAPSULE | THORNE RESEARCH INC. | CANCELLED POST MARKET | 02231938 |
2 · Same class — other molecules in ATC V06DX
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Other Combinations Of Nutrients | AMD TAB · BORACELLE CAPSULES 500MG · BORACELLE OIL OF BORAGE SEED 23.5% GAMMA LIN · BORAGE OIL · +11 more | 15 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC V06D
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| V06D | Other Nutrients | 1 | 0 |
| V06DB | Fat/Carbohydrates/Proteins/Minerals/Vitamins, Comb | 2 | 0 |
| V06DC | Glucose | 1 | 0 |
| V06DD | Amino Acids, Incl Combinations With Polypeptides | 1 | 0 |
| V06DE | Amino Acids/Carbohydrates/Minerals/Vitamins, Comb | 1 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is EFAMOL PURE LIQUID EVENING PRIMROSE OIL called?
Also recorded in Canada as: Gamma-linolenic acid (GLOBAL), Gamolenic acid (UK), Efamast (UK), Epogam (UK), Evening Primrose Oil (US), Primosa (IN).
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.